1. Anti-infection Epigenetics
  2. HIV hnRNP
  3. BMMP

BMMP 是一种抗 HIV-1 试剂和 hnRNP M 调节剂。BMMP 可调控 hnRNP M 的功能,从而抑制 CD44 mRNA 的表达。BMMP 可在病毒进入细胞后的阶段诱导 HIV 病毒核心发生异常脱壳。BMMP 可抑制经 TGF-β 刺激的肺癌细胞迁移。BMMP 可抑制 HIV-1 的逆转录与复制,但不会抑制病毒粒子的释放。BMMP 通过与结合 CA 蛋白的杂环化合物不同的机制发挥抗 HIV-1 活性。BMMP 可用于人类免疫缺陷病毒感染和非小细胞肺癌的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

BMMP

BMMP Chemical Structure

CAS No. : 748785-70-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 HIV 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

BMMP is an anti-HIV-1 agent and hnRNP M modulator. BMMP modulates hnRNP M function to suppress CD44 mRNA expression. BMMP induces abnormal uncoating of the HIV viral core at the post-entry step. BMMP suppresses migration of TGF-β-stimulated lung carcinoma cells. BMMP suppresses HIV-1 reverse transcription and replication without inhibiting virion release. BMMP exerts anti-HIV-1 activity via a mechanism distinct from CA protein-binding heterocyclic compounds. BMMP can be used for the research of human immunodeficiency virus infection and non-small cell lung cancer[1][2].

体外研究
(In Vitro)

BMMP (20 μM;2 天) 不会降低 293T 或 M8166 细胞的存活率[1]
BMMP (20 μM;3 天) 可在 293T 和 M8166 细胞中抑制 HIV-1 的全周期复制,使其复制水平降至对照组的 30%[1]
BMMP (20 μM) 不影响 HIV-1 病毒粒子从 293T 细胞中的释放[1]
BMMP (20 μM;1 天) 不会显著改变由 293T 细胞产生的 HIV-1 病毒粒子的感染性[1]
BMMP (20 μM;1 天) 可强效抑制 M8166 细胞中 HIV-1 的早期感染性,使其降至对照组水平的 10%以下[1]
BMMP (20 μM;2 天) 不影响 HIV-1 逆转录,但会抑制 293T 细胞中病毒 DNA 的核定位与整合,使 2-LTR DNA 降至对照组水平的 60%,Alu-LTR DNA 降至对照组水平的 46%[1]
BMMP (20 μM;1 天) 可使受感染 HeLa 细胞中的 HIV-1 CA 蛋白失稳[1]
BMMP (20 μM;1 天) 不会改变 hnRNP M 的核定位,但会降低受感染 HeLa 细胞内的 HIV-1 CA 蛋白水平[1]
BMMP (20 μM;1 天) 可抑制对照组和 hnRNP M 敲低的 HeLa 细胞中 HIV-1 的早期感染性,表明 hnRNP M 不参与 BMMP 的抗 HIV 活性[1]
BMMP (0.1-100 μM;2 天) 在 0.1-50 μM 浓度下不会降低 A549 细胞活力,而 100 μM 的 BMMP 则表现出轻微毒性[1]
BMMP (0.1-100 μM;24 小时) 以浓度依赖的方式抑制 TGF-β 诱导的 A549 细胞迁移,在 20 μM 时抑制作用近乎完全[1]
BMMP (20 μM;1 小时-1 天) 可轻度降低波形蛋白的 mRNA 水平,但无法抑制 A549 细胞中由 TGF-β 诱导的 EMT 标志物变化[1]
BMMP (20 μM;1 天) 可降低 A549 细胞中由 TGF-β 诱导的 CD44sCD44v8CD44v10 mRNA 水平的升高[1]
BMMP (20 μM;1 天) 可通过 hnRNP M 降低 TGF-β 诱导的 A549 细胞中 CD44 mRNA 的表达,该效应在 hnRNP M 敲低细胞中被消除[1]
BMMP (20 μM;up to 100 小时) 可抑制 HIV-1 NL4-3 毒株在人 T 淋巴母细胞样 M8166 细胞中的复制[2]
BMMP 在无细胞表面等离子体共振实验中不与 HIV-1 Pr55GagCA 蛋白直接相互作用[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: human kidney cell line 293T, human T-lymphoblastoid cell line M8166
Concentration: 20 μM
Incubation Time: 2 d
Result: Showed no significant toxicity to 293T or M8166 cells.
Maintained relative cell viability at ~100% compared to untreated controls.

Western Blot Analysis[1]

Cell Line: HeLa cells infected with HIV-1
Concentration: 20 μM
Incubation Time: 1 d
Result: Destabilized the HIV-1 CA (p24) protein, reducing its detectable levels compared to untreated controls.

Immunofluorescence[1]

Cell Line: HeLa cells infected with HIV-1
Concentration: 20 μM
Incubation Time: 1 d
Result: Did not alter the nuclear localization of hnRNP M.
Reduced detectable p24 (CA) protein levels.

Cell Viability Assay[1]

Cell Line: human lung carcinoma cell line A549
Concentration: 0.1 μM; 0.5 μM; 1 μM; 5 μM; 20 μM; 50 μM; 100 μM
Incubation Time: 2 d
Result: At 0.1-50 μM did not significantly reduce A549 cell viability (relative viability ~90-105% of control).
At 100 μM caused a slight reduction to ~85% of control.

Cell Migration Assay [1]

Cell Line: TGF-β-stimulated human lung carcinoma cell line A549
Concentration: 0.1 μM; 0.5 μM; 1 μM; 5 μM; 20 μM; 50 μM; 100 μM
Incubation Time: 24 h total incubation with TGF-β stimulation
Result: Inhibited TGF-β-induced A549 cell migration in a concentration-dependent manner.
Reduced migration by ~50% at 0.5 μM.
Nearly completely inhibited migration at 20 μM.
Maintained significant inhibitory activity at 100 μM.

RT-PCR[1]

Cell Line: TGF-β-stimulated human lung carcinoma cell line A549
Concentration: 20 μM
Incubation Time: 1 h, 3 h, 6 h, or 1 d incubation with TGF-β stimulation
Result: Did not alter E-cadherin mRNA levels.
Slightly reduced vimentin mRNA levels at 1 d post-TGF-β stimulation.
Did not significantly reduce N-cadherin, snail, or fibronectin mRNA levels after 1 d of TGF-β stimulation.

RT-PCR[1]

Cell Line: TGF-β-stimulated human lung carcinoma cell line A549
Concentration: 20 μM
Incubation Time: 1 d incubation with TGF-β stimulation
Result: Reduced TGF-β-induced increases in CD44s, CD44v8, and CD44v10 mRNA levels in A549 cells.

RT-PCR[1]

Cell Line: TGF-β-stimulated human lung carcinoma cell line A549 (hnRNP M-knockdown)
Concentration: 20 μM
Incubation Time: 1 d incubation with TGF-β stimulation
Result: Did not reduce TGF-β-induced increases in CD44s, CD44v8, or CD44v10 mRNA levels in hnRNP M-knockdown A549 cells.
分子量

273.38

Formula

C13H11N3S2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
BMMP
目录号:
HY-182514
需求量: